EPO and chronic kidney disease: Although inadequate production of erythropoietin is the most important factor in the pathogenesis of anaemia in chronic kidney disease, other factors play a role and contribute to mild anaemia that is often present despite the use of recombinant human erythropoietin or other erythropoiesis stimulating agents (ESA).